SCHEMBL1008997

SCHEMBL1008997

c1ccc2cc(Nc3ccc4ncccc4c3)ccc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.58
POLB P06746 2/20 0.58
MAPT P10636 2/20 0.58
MEN1 O00255 1/20 0.58
KMT2A Q03164 1/20 0.58
ALDH1A1 P00352 7/20 0.58
HSD17B10 Q99714 2/20 0.58
HPGD P15428 2/20 0.58
CYP3A4 P08684 1/20 0.58
PABPC1 P11940 1/20 0.55
GRM4 Q14833 2/20 0.55
ABCB1 P08183 1/20 0.55
ABCC1 P33527 1/20 0.55
ABCG2 Q9UNQ0 1/20 0.55
EGFR P00533 1/20 0.54
RAB9A P51151 4/20 0.53
SMN1; SMN2 Q16637 3/20 0.50
HTT P42858 2/20 0.50
KDM4E B2RXH2 1/20 0.50
TP53 P04637 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1011248 0.89 PABPC1 (0.59) NPC1POLBMAPTMEN1KMT2A
SCHEMBL6748149 0.86 NPC1 (0.63) NPC1POLBMAPTMEN1KMT2A
SCHEMBL2791886 0.85 ABCB1 (0.61) NPC1POLBMAPTMEN1KMT2A
SCHEMBL5758552 0.84 NPC1 (0.60) NPC1POLBMAPTMEN1KMT2A
SCHEMBL25389520 0.83 ALDH1A1 (0.66) NPC1POLBMAPTMEN1KMT2A
SCHEMBL28242830 0.83 NPC1 (0.67) NPC1POLBMAPTMEN1KMT2A
SCHEMBL9702763 0.83 NPC1 (0.59) NPC1POLBMAPTMEN1KMT2A
SCHEMBL5655823 0.82 NPC1 (0.88) NPC1POLBMAPTMEN1KMT2A
SCHEMBL14582251 0.82 PABPC1 (0.52) NPC1POLBMAPTMEN1KMT2A
SCHEMBL28243562 0.82 NPC1 (0.66) NPC1POLBMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9115112-B2 Aminoanthracene derivative and an organic electroluminescent element employing the same DOOSAN CORPORATION (KR) 2015-08-25 US disclosed
EP-1801189-B1 Synergistic lubricating oil composition containing a mixture of a benzo[b]perhydroheterocyclic arylamine and a diarylamine CHEVRON ORONITE CO (US) 2012-11-07 EP disclosed
US-20120161615-A1 AMINOANTHRACENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME DOOSAN CORPORATION (KR) 2012-06-28 US disclosed
US-8003583-B2 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions CHEVRON ORONITE COMPANY LLC (US) 2011-08-23 US disclosed
US-8003583-B2 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions CHEVRON ORONITE COMPANY LLC (US) 2011-08-23 US disclosed
US-8003583-B2 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions CHEVRON ORONITE COMPANY LLC (US) 2011-08-23 US disclosed
EP-1801104-B1 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions CHEVRON ORONITE CO (US) 2011-01-05 EP disclosed
EP-1801104-B1 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions CHEVRON ORONITE CO (US) 2011-01-05 EP disclosed
WO-2010147318-A2 AMINOANTHRACENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME 주식회사 두산 (KR) 2010-12-23 WO disclosed
US-7501386-B2 Lubricants for automotive and truck crankcase lubricants; as well as transmission lubricants, gear lubricants, hydraulic fluids, compressor oils, diesel and marine lubricants; superior oxidation inhibition; Phenyl-(1,2,3,4-tetrahydro-quinolin-6-yl)-amine, diphenylamine CHEVRON ORONITE COMPANY, LLC (US) 2009-03-10 US disclosed
EP-1801104-A2 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions Chevron Oronite Company LLC (US) 2007-06-27 EP disclosed
EP-1801104-A2 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions Chevron Oronite Company LLC (US) 2007-06-27 EP disclosed
EP-1801189-A2 Synergistic lubricating oil composition containing a mixture of a benzo[b]perhydroheterocyclic arylamine and a diarylamine Chevron Oronite Company LLC (US) 2007-06-27 EP disclosed
US-20070142243-A1 Synergistic lubricating oil composition containing a mixture of a benzo[b]perhydroheterocyclic arylamine and a diarylamine CHEVRON ORONITE COMPANY LLC 2007-06-21 US disclosed
US-20070142246-A1 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions CHEVRON ORONITE COMPANY LLC 2007-06-21 US disclosed
US-20070142246-A1 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions CHEVRON ORONITE COMPANY LLC 2007-06-21 US disclosed
US-20070142246-A1 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions CHEVRON ORONITE COMPANY LLC 2007-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142246-A1 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions AHR, ARNT, HRH2 NPC1 1276/4885POLB 129/4885MAPT 2668/4885
US-20120161615-A1 AMINOANTHRACENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME AADAT, ALAD, AAAS NPC1 4829/4885POLB 2038/4885MAPT 2807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.